Reliv International Reports First-Quarter Financial Results for 2013

Reliv International Reports First-Quarter Financial Results for 2013

CHESTERFIELD, Mo., May 1, 2013 (GLOBE NEWSWIRE) -- Reliv International, Inc.
(Nasdaq:RELV), a maker of nutritional supplements that promote optimal health,
today reported its financial results for the first quarter of 2013.

First-Quarter Results

Reliv reported net sales of $18.9 million for the first quarter of 2013,
compared to net sales of $19.7 million for the first quarter of 2012. U.S. net
sales declined by 4.2 percent for the quarter compared to the same quarter in
2012. International net sales for the quarter declined 5.7 percent, with the
continued growth in Europe of 26.6 percent offset by declines in Asia and
Australia of 55.3 percent and 17.0 percent, respectively.

The company reported net income of $195,000, or $0.02 per diluted share, for
the first quarter of 2013 compared to net income of $532,000, or $0.04 per
diluted share, for the first quarter of 2012. Income from operations for the
first quarter of 2013 was $435,000 compared to $914,000 in the same quarter of

"Sales declines in Asia and Australia coupled with investments in new staffing
in those markets significantly contributed to the decline in profitability
overall," said Robert L. Montgomery, chairman and chief executive officer of
Reliv. "We have devoted resources and launched a series of enhancements to our
business model in these markets in an effort to spur growth. Examples include
a preferred customer program in Australia and new programs in the Philippines
intended to increase attention and focus on retail sales by distributors. I
believe such proactive measures will reenergize these markets."

"Reliv's European expansion continued as the first quarter of 2013 marked
Europe's 14th consecutive quarter of year-over-year net sales growth," he
added. "France officially became Reliv's 16^th country of operation in April
and was celebrated with well-attended events across the country. Momentum in
Europe continues to build and we are devoting resources to fuel additional
sales growth."

"In the United States, Reliv launched our latest product, LunaRich X™, and a
new points-based LunaRich wellness system in January 2013," Montgomery
continued. "LunaRich X is the most concentrated form of lunasin currently
available. Lunasin is the peptide scientists have identified as the key to
many of soy's documented health benefits. LunaRich X has been welcomed
enthusiastically by distributors and consumers, accounting for 7.2 percent of
U.S. net sales in the first quarter of 2013. We anticipate growth in LunaRich
X sales, as additional research is published and market awareness increases."

"On March 1, 2013, Reliv implemented a new pricing structure in the United
States, pairing a modest price increase with increased servings per unit,
offset by a reduced shipping charge," he said. "The resulting cost per serving
is only pennies higher for most products, and feedback from our distributors
has been positive. Adjusting servings per unit to provide a full month's
supply helps facilitate regular monthly sales and the reduced shipping helps
eliminate a common point-of-sale objection."

"The network marketing industry is seeing e-commerce becoming as important as
in-person sales, and Reliv is taking steps to stay in front of this shift in
our industry's business model," Montgomery said. "Reliv is nearing the
completion of the first step in this process, creating a custom content
management system. This system will provide the platform to pursue additional
online upgrades. This year will also see the launch of a new online shopping
cart, designed to make it easier for consumers to purchase our products."

"As we work to build for the future, we continue to reduce costs where
appropriate and to maintain a strong balance sheet," he added. Reliv had cash
and cash equivalents of $5.87 million as of March 31, 2013, virtually
unchanged from $5.80 million on December 31, 2012.

As of March 31, 2013, Reliv had 56,040 distributors – a decline of 4.3 percent
from March 31, 2012 – of which 5,600 are Master Affiliate level and above.
Master Affiliate is the level at which distributors are eligible to earn
generation royalties.

About Reliv International, Inc.

Reliv International, based in Chesterfield, Mo., produces nutritional
supplements that promote optimal nutrition along with premium skincare
products. Reliv supplements address essential nutrition, weight loss, athletic
performance, digestive health, women's health, anti-aging and healthy energy.
Reliv is the exclusive provider of LunaRich® products, which optimize levels
of lunasin, the peptide behind many of soy's health benefits. The company
sells its products through an international network marketing system of
independent distributors in 16 countries. Learn more about Reliv at, or on Facebook, Twitter or YouTube.

Statements made in this news release that are not historical facts are
"forward-looking" statements (as defined in the Private Securities Litigation
Reform Act of 1995) that involve risks and uncertainties and are subject to
change at any time. These forward-looking statements may include, but are not
limited to, statements containing words such as "may," "should," "could,"
"would," "expect," "plan," "anticipate," "believe," "estimate," "predict,"
"potential," "continue" or similar expressions. Factors that could cause
actual results to differ are identified in the public filings made by Reliv
with the Securities and Exchange Commission. More information on factors that
could affect Reliv's business and financial results are included in its public
filings made with the Securities and Exchange Commission, including its Annual
Report on Form 10-K and Quarterly Reports on Form 10-Q, copies of which are
available on the Company's web site,

                       – FINANCIAL HIGHLIGHTS FOLLOW –

Reliv International, Inc. and Subsidiaries                      
Consolidated Balance Sheets                                     
                                                  March 31      December 31
                                                  2013          2012
Current Assets:                                                 
Cash and cash equivalents                          $5,865,285    $5,801,042
Accounts receivable, less allowances of $27,500 in 148,377       247,087
2013 and $35,700 in 2012
Accounts and note due from employees and           139,052       109,346
Inventories                                        5,370,955     5,262,916
Other current assets                               1,790,567     1,070,301
Total current assets                               13,314,236    12,490,692
Other assets                                       5,870,734     5,656,077
Net property, plant and equipment                  6,995,023     7,111,772
Total Assets                                       $26,179,993   $25,258,541
Liabilities and Stockholders' Equity                            
Total current liabilities                          $7,428,737    $6,614,631
Long-term debt, less current maturities            2,297,859     2,401,312
Other non-current liabilities                      681,838       660,728
Stockholders' equity                               15,771,559    15,581,870
Total Liabilities and Stockholders' Equity         $26,179,993   $25,258,541
Consolidated Statements of Operations                           
                                                  Three months ended March 31
                                                  2013          2012
                                                  (Unaudited)   (Unaudited)
Product sales                                      $16,889,458   $17,614,840
Handling & freight income                          1,967,806     2,128,804
Net Sales                                          18,857,264    19,743,644
Costs and expenses:                                             
Cost of products sold                              3,903,858     3,900,581
Distributor royalties and commissions              7,003,204     7,455,160
Selling, general and administrative                7,515,488     7,474,246
Total Costs and Expenses                           18,422,550    18,829,987
Income from operations                             434,714       913,657
Other income (expense):                                         
Interest income                                    37,164        9,314
Interest expense                                   (17,502)      (30,919)
Other expense                                      (26,575)      (22,668)
Income before income taxes                         427,801       869,384
Provision for income taxes                         233,000       337,000
Net Income                                         $194,801      $532,384
Earnings per common share - Basic                  $0.02         $0.04
Weighted average shares                            12,620,000    12,512,000
Earnings per common share - Diluted                $0.02         $0.04
Weighted average shares                            12,708,000    12,633,000
Cash dividends declared per common share           $--         $--

Reliv International, Inc. and Subsidiaries
Net sales by                                                             
(in           Three months ended March 31,                    Change from
             2013                    2012                    prior year
             Amount       % of Net   Amount       % of Net   Amount       %
                           Sales                   Sales
United States 15,109       80.1%      15,770       79.9%      (661)        -4.2%
Australia/New 448          2.4%       540          2.7%       (92)         -17.0%
Canada        554          2.9%       550          2.8%       4            0.7%
Mexico        278          1.5%       287          1.4%       (9)          -3.1%
Europe        2,020        10.7%      1,595        8.1%       425          26.6%
Asia          448          2.4%       1,002        5.1%       (554)        -55.3%
Consolidated  18,857       100.0%     19,744       100.0%     (887)        -4.5%
The following table sets forth, as of March 31, 2013 and 2012, the number of our
active distributors and Master Affiliates and above. The total number of active
distributors includes Master Affiliates and above. We define an active distributor as
one that enrolls as a distributor or renews its distributorship during the prior
twelve months. Master Affiliates and above are distributors that have attained the
highest level of discount and are eligible for royalties generated by Master
Affiliates and above in their downline organization.
Active Distributors and Master Affiliates and above by Market             
             As of 3/31/2013         As of 3/31/2012         Change in %
                           Master                  Master                  Master
             Active       Affiliates Active       Affiliates Active       Affiliates
              Distributors and Above  Distributors and Above  Distributors and

United States 40,020       3,960      42,910       4,550      -6.7%        -13.0%
Australia/New 1,710        180        1,950        120        -12.3%       50.0%
Canada        1,310        170        1,340        190        -2.2%        -10.5%
Mexico        1,340        100        1,640        140        -18.3%       -28.6%
Europe        7,090        730        4,900        480        44.7%        52.1%
Asia          4,570        460        5,790        500        -21.1%       -8.0%
Consolidated  56,040       5,600      58,530       5,980      -4.3%        -6.4%

CONTACT: Steve Albright
         Chief Financial Officer
         (636) 733-1305
         Fred Nielson
         Investor Relations
         (636) 733-1314
         Mark Murphy
         Media Relations
         (636) 733-1391
Press spacebar to pause and continue. Press esc to stop.